Crossmark

Walking-adaptability therapy after stroke: results of a randomized controlled trial

Crossref DOI link: https://doi.org/10.1186/s13063-021-05742-3

Published Online: 2021-12-15

Published Print: 2021-12

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Timmermans, C. https://orcid.org/0000-0001-8451-2326
Roerdink, M.

Meskers, C. G. M.

Beek, P. J. https://orcid.org/0000-0002-0917-8548
Janssen, T. W. J.
License Information

Text and Data Mining valid from 2021-12-01

Version of Record valid from 2021-12-15
More Information

Article History

Received: 14 April 2020

Accepted: 20 October 2021

First Online: 15 December 2021

Declarations

:

: The protocol for the study was approved by the Medical Ethical Reviewing Committee of VU University Medical Centre (Amsterdam, The Netherlands; protocol number 2013/53 and the Central Committee on Research Involving Human Subjects, CCMO, protocol number NL 42461.029.13). All participants provided written informed consent before the start of the trial.

: Informed consent was obtained from the persons who appear in Fig. .

: No conflict of interest. MR and PJB are inventors of rehabilitation treadmills that include visual context for foot placement. Vrije Universiteit Amsterdam granted this invention exclusively to ForceLink (Culemborg, The Netherlands), an industrial partner of Vrije Universiteit Amsterdam. ForceLink merged with Motek (Amsterdam), who is currently the manufacturer of the C-Mill treadmill and assignee of a patent for rehabilitation treadmills with visual context for foot placement, with MR and PJB listed as inventors. MR and PJB did not receive any reimbursements, fees, funding, or salary from ForceLink or Motek, nor did they benefit personally from patent revenues.

Document is current

Any future updates will be listed below